Beta-Carotene, Vitamin A, and Eye Health

Almost everything people believe about carrots and eyesight is half right. Carrots really are one of the densest food sources of beta-carotene on earth. Beta-carotene really does become vitamin A inside your body. Vitamin A really is the molecule that lets your retina detect light — without it you go blind, and the first thing you lose is night vision. All of that is true, and it is remarkable. What is not true is the part everyone remembers: that eating more carrots will sharpen vision that is already normal. This page walks the whole chain honestly — the chemistry, the conversion, the physiology of seeing, what deficiency actually does to an eye, why food beta-carotene cannot poison you the way retinol supplements can, why your palms may turn orange if you overdo it, and the one genuinely dangerous thing in this whole story: high-dose beta-carotene supplements in smokers, which two large trials found increased lung cancer.


Table of Contents

  1. What Beta-Carotene Actually Is
  2. How Your Body Turns It Into Vitamin A
  3. The Conversion Ratio, and Why It Varies So Much
  4. How Vitamin A Makes Sight Possible
  5. Night Blindness and What Real Deficiency Looks Like
  6. The Honest Limit: Correction, Not Enhancement
  7. The Supplement Trials: ATBC, CARET, and Smokers
  8. Why Food Beta-Carotene Does Not Cause Vitamin A Toxicity
  9. Carotenemia: The Benign Orange Skin
  10. Macular Degeneration and the AREDS Story
  11. How Much Vitamin A Carrots Supply, and What Helps Absorption
  12. Key Research Papers
  13. Connections
  14. Featured Videos

What Beta-Carotene Actually Is

Beta-carotene is a pigment. It is a long, symmetrical hydrocarbon chain with a ring at each end, built out of forty carbon atoms, and its backbone is a run of alternating single and double bonds. That alternating run is what physicists call a conjugated system, and it is the reason the molecule is orange: the electrons in a long conjugated chain absorb blue and green light and let red and yellow pass through to your eye. The same structural feature that makes a carrot orange is the feature that makes it useful to you.

Beta-carotene belongs to a family called the carotenoids, of which several hundred are known in plants. Only a handful matter nutritionally, and they split into two groups. The provitamin A carotenoids — beta-carotene, alpha-carotene, and beta-cryptoxanthin — can be cut apart by human enzymes to make vitamin A. The non-provitamin carotenoids — lutein, zeaxanthin, lycopene — cannot; they do other jobs, several of them in the eye. A carrot supplies mostly beta-carotene, with a substantial amount of alpha-carotene alongside it and small quantities of lutein. Purple carrots add anthocyanins; yellow carrots are richer in lutein; red carrots carry lycopene, the tomato pigment.

Beta-carotene is fat-soluble and essentially insoluble in water. Inside the carrot it is not floating free but packed into crystalline deposits inside plant cells, wrapped in tough cellulose walls. That physical packaging turns out to matter enormously for how much you actually absorb, which is the subject of the companion page on cooking, fat, and absorption.

Back to Table of Contents

How Your Body Turns It Into Vitamin A

Vitamin A is not one molecule but a small family: retinol (the alcohol form, the storage and transport form), retinal (the aldehyde, the form your retina uses to see), and retinoic acid (the acid, which acts like a hormone controlling gene expression in skin, immune cells, and developing tissue). Beta-carotene is the plant precursor of all three.

The key step happens mostly in the cells lining your small intestine. An enzyme called beta-carotene 15,15'-oxygenase — abbreviated BCO1, and in the older literature BCMO1 — snips the beta-carotene molecule exactly in the middle. Because beta-carotene is symmetrical, one clean central cut theoretically yields two molecules of retinal. Lindqvist and Andersson purified the human enzyme in 2002 and showed directly that it performs this central cleavage. The retinal produced is then either reduced to retinol and packaged into chylomicrons for delivery to the liver, or oxidised onward to retinoic acid.

A second enzyme, BCO2, cuts carotenoids off-centre instead of in the middle, producing fragments that are not vitamin A. BCO2 handles carotenoids that BCO1 does not take, and it seems to act partly as a housekeeping system that clears carotenoids out of tissues. The existence of two competing routes is one reason the yield of vitamin A from a given amount of beta-carotene is not a fixed number.

Your liver stores vitamin A, and it stores a lot of it — a well-nourished adult liver holds enough to cover months of zero intake. This is why vitamin A status changes slowly, why a single carrot-heavy week does nothing measurable to a replete person, and why deficiency, when it happens, is the end point of a long slide rather than a sudden event.

Back to Table of Contents

The Conversion Ratio, and Why It Varies So Much

If beta-carotene splits neatly into two retinals, you might expect roughly two units of beta-carotene to buy one unit of vitamin A. In a test tube that is close to right. In a human eating a carrot it is nowhere near right, and the gap is one of the most practically important facts in this whole subject.

The United States Institute of Medicine, when it set the modern reference intakes in 2001, adopted a conversion of 12 micrograms of dietary beta-carotene to 1 microgram of retinol, and 24 to 1 for alpha-carotene and beta-cryptoxanthin. Purified beta-carotene dissolved in oil converts far better — about 2 to 1. The difference between 2 and 12 is not chemistry; it is the food matrix. Beta-carotene locked in crystalline form inside intact plant cells simply never reaches the enzyme.

This is why nutrition labels now use retinol activity equivalents (RAE) rather than the older international units. One microgram RAE means one microgram of actual retinol activity, whatever it came from. A raw carrot supplies roughly 835 micrograms RAE per 100 grams, so a medium carrot of about 60 grams delivers on the order of 500 micrograms RAE — well over half the adult daily requirement, which is 900 micrograms RAE for men and 700 for women. Cooked carrots score slightly higher per 100 grams, partly because the carotene becomes more extractable.

Averages, though, hide a huge spread between individuals. Hickenbottom and colleagues used a double-tracer design in 2002 in 11 healthy, well-fed men living in a controlled environment: mean absorption of the labelled beta-carotene was 2.235 percent, only 6 of the 11 men had blood levels high enough to measure its conversion at all, and the authors concluded that the vitamin A activity of beta-carotene, even under controlled conditions, can be surprisingly low and variable. Leung and colleagues traced part of that variation to its source in 2009: two common single-nucleotide polymorphisms in the BCMO1 gene measurably reduced beta-carotene conversion in female volunteers who carried them. Their paper notes that beta-carotene conversion is highly variable in up to 45% of healthy individuals. The two variants had allele frequencies of 42 and 24%; with both changes together, the enzyme's activity in the laboratory was 57% lower, and in women carrying both variants a blood marker of conversion (the retinyl palmitate to beta-carotene ratio after a test dose) was 69% lower. Later work by Lietz, and a broad review by Borel and Desmarchelier in 2017, confirmed that a substantial fraction of the population carries variants that make them relatively poor converters. Converter status is not something people are routinely tested for. The practical implication is simply that plant carotenoids alone are a less reliable vitamin A supply for some people than for others, and that a diet containing some preformed vitamin A — eggs, liver, butter, whole dairy, oily fish — covers that uncertainty in a way an all-vegetable diet does not.

Back to Table of Contents

How Vitamin A Makes Sight Possible

Here is the part that genuinely deserves the reputation carrots have. Vitamin A is not merely helpful to vision. It is the molecule that does vision. Nothing else in your body can do its job.

At the back of your eye, the rod and cone cells each carry stacks of membranes packed with a light-sensitive protein. In rods that protein is rhodopsin: a large protein called opsin with a single small molecule tucked into a pocket inside it. That small molecule is 11-cis-retinal — a bent form of vitamin A aldehyde.

When a photon strikes it, the retinal absorbs the energy and straightens: the bent 11-cis form isomerises to the straight all-trans form, a step that laser measurements by Schoenlein and colleagues in 1991 showed is essentially complete in only 200 femtoseconds. That change of shape is the entire trick. A straightened retinal no longer fits its pocket, so it forces the surrounding opsin protein to change shape too. The altered opsin activates a signalling protein called transducin, which switches on an enzyme that destroys cyclic guanosine monophosphate (cyclic GMP), which causes ion channels in the cell membrane to close, which changes the cell's voltage — and that voltage change is a nerve signal. George Wald won a share of the 1967 Nobel Prize in Physiology or Medicine for working this out, and his 1968 Science paper is still the clearest short account of it.

The straightened retinal then falls out of the protein and has to be carried to neighbouring cells, bent back into the 11-cis shape, and returned. This recycling loop — the visual cycle — runs continuously, millions of times over, and it leaks. A little retinal is lost on every pass, and that loss has to be made good from the body's vitamin A stores. That is the actual, literal mechanism by which eating vitamin A lets you see. When stores run down, the loop cannot be resupplied fast enough, rhodopsin cannot be regenerated at normal speed, and vision fails — starting in the dark, where the demand on rhodopsin is highest.

Back to Table of Contents

Night Blindness and What Real Deficiency Looks Like

Vitamin A deficiency has a characteristic sequence, and it is worth knowing because it explains exactly where carrots do and do not help.

The first symptom is impaired dark adaptation, then frank night blindness (nyctalopia). Someone in this stage sees perfectly well in daylight and cannot find their way across a dim room. It is a rod-cell problem: rods handle low light and depend most heavily on rhodopsin turnover. This stage is fully reversible, sometimes within days of restoring vitamin A.

If deficiency continues, it moves from the retina to the surface of the eye. The conjunctiva dries and thickens (conjunctival xerosis), and foamy grey-white patches called Bitot's spots appear on the white of the eye. Then the cornea itself dries, ulcerates, and in the final stage liquefies — keratomalacia — which destroys the eye permanently within days. The whole spectrum is called xerophthalmia, and Alfred Sommer's 1998 review in Progress in Retinal and Eye Research remains the standard clinical description.

This is not a historical curiosity. Vitamin A deficiency remains a leading cause of preventable childhood blindness worldwide, and it does more than blind: it cripples immune defence at mucosal surfaces, so deficient children die of measles, diarrhoea, and respiratory infection at higher rates. Sommer's field trials in Indonesia in the 1980s produced the finding that changed global child health policy — that simple vitamin A supplementation reduced child mortality substantially. The 2022 Cochrane review by Imdad and colleagues (an update of their 2017 review, which found no new trials), pooling trials in children aged six months to five years, put the reduction in all-cause mortality at roughly 12 percent. Wiseman and colleagues described the self-reinforcing loop in 2017: deficiency causes infection, infection depletes vitamin A further, and the cycle tightens.

Against that background, the humble carrot looks different. In populations where provitamin A vegetables are the main dietary source of vitamin A, orange and yellow roots are not a garnish — they are a public health intervention.

Back to Table of Contents

The Honest Limit: Correction, Not Enhancement

Now the correction. Carrots restore vision that vitamin A deficiency has taken away. They do not improve vision that is already normal.

The reason is a ceiling, not a shortage. The visual cycle needs a supply of retinal sufficient to keep rhodopsin regenerating at full speed. Once that supply is adequate, more retinal does not make rhodopsin regenerate faster, does not add rod cells, does not widen your pupil, and does not change the optics of your cornea and lens. A replete person's liver already holds months of reserve; adding to a full tank does not make the engine run better. Someone with normal vitamin A status who eats a kilogram of carrots will have orange palms and unchanged night vision.

It follows that carrots also do nothing for the reasons most people actually see poorly. Myopia, hyperopia, and astigmatism are shape problems — the eyeball is too long, too short, or unevenly curved, so light focuses in the wrong place. No nutrient reshapes an eyeball. Presbyopia is the stiffening of the lens with age. Cataract is clouding of the lens protein. Glaucoma is optic nerve damage, usually with raised pressure. None of these is a vitamin A deficiency, and none is corrected by diet.

Saying this plainly does not diminish carrots. It puts them where they belong: as an excellent, cheap, reliable source of a nutrient your retina cannot function without — keeping a system intact rather than upgrading it.

Back to Table of Contents

The Supplement Trials: ATBC, CARET, and Smokers

This section is the most important on the page, and it is the one place where the beta-carotene story turns genuinely dangerous.

By the late 1980s the observational evidence looked excellent: people who ate more carotenoid-rich vegetables, and people with higher blood beta-carotene, got less lung cancer. The obvious next step was to give beta-carotene as a pill and watch cancer rates fall. Two large randomised trials set out to do exactly that, and both found the opposite.

The ATBC trial (Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study), published in the New England Journal of Medicine in 1994, randomised 29,133 male smokers in Finland to beta-carotene (20 mg a day), alpha-tocopherol, both, or neither, and followed them for five to eight years. Among the men receiving beta-carotene, lung cancer incidence was about 18 percent higher, and total mortality was higher as well.

The CARET trial (Beta-Carotene and Retinol Efficacy Trial), reported by Omenn and colleagues in 1996, gave 30 mg of beta-carotene plus 25,000 IU of vitamin A (as retinyl palmitate) a day to 18,314 smokers, former smokers, and asbestos-exposed workers. It was stopped 21 months earlier than planned, because the treated group had roughly 28 percent more lung cancer (relative risk 1.28), more deaths from lung cancer (relative risk 1.46) and higher overall mortality (relative risk 1.17).

A third trial, the Physicians' Health Study reported by Hennekens and colleagues in the same 1996 issue, gave beta-carotene (50 mg on alternate days) to 22,071 male physicians — of whom 11 percent were current smokers and 39 percent former smokers at the start — and found no effect on cancer or cardiovascular disease in either direction over twelve years; among the current and former smokers there were also no significant differences. Taken together the three trials point at the same conclusion, and Druesne-Pecollo's 2010 meta-analysis of randomised trials confirmed it: high-dose beta-carotene supplements raise cancer risk specifically in smokers and asbestos-exposed people, and do nothing measurable in everyone else. That meta-analysis of 9 randomised trials found no effect on all cancers combined (relative risk 1.01), but at 20 to 30 mg a day both lung cancer (relative risk 1.16) and stomach cancer (relative risk 1.34) were significantly increased; in smokers and asbestos workers the figures were 1.20 for lung cancer and 1.54 for stomach cancer.

Why would a pigment from vegetables do this? The leading explanation is that beta-carotene behaves differently in a lung full of tobacco smoke. At high concentrations and under the oxidative conditions of a smoker's airway, beta-carotene can break down into products that behave as pro-oxidants rather than antioxidants, and there is evidence they can interfere with normal retinoid signalling in lung tissue. This is a dose-and-environment problem, not a verdict on the molecule.

The distinction that matters for anyone reading this page is sharp:

This is the general lesson of the supplement era in one example: an isolated compound at pharmacological dose acts as a drug, whatever food it was originally found in. Our section on dangerous supplements covers the same pattern across other products.

Back to Table of Contents

Why Food Beta-Carotene Does Not Cause Vitamin A Toxicity

Preformed vitamin A — retinol and retinyl esters, the form in liver, cod liver oil, and many supplements — genuinely can poison you. Acute overdose causes headache, nausea, and vomiting; chronic excess causes liver damage, bone loss, and hair loss; and high intake in early pregnancy causes birth defects. The tolerable upper intake level for adults is set at 3,000 micrograms of preformed vitamin A per day, and it is a real limit.

Beta-carotene from food does not do this, and the reason is elegant. The conversion is regulated by your own vitamin A status. When stores are full, BCO1 activity is turned down; when stores are low, it is turned up. Novotny and colleagues demonstrated the dose side of the same control directly in 2010: as the dietary dose of beta-carotene rises, the proportion converted to vitamin A falls. When their 7 volunteers took 40 mg instead of 20 mg of labelled beta-carotene, the beta-carotene measured in their blood increased 2-fold, but the vitamin A made from it increased only 36 percent. The unconverted surplus is simply stored in fat and skin, or excreted, rather than being pushed into the retinol pool.

The practical result is that there is no recorded case of vitamin A toxicity from eating carrots, or from any other provitamin A vegetable, and the Institute of Medicine set no upper limit for provitamin A carotenoids from food. It advised against high-dose beta-carotene supplements — for the smoking-related reasons above — but not against carrots. The upper limit for vitamin A applies to preformed vitamin A, not to carrots. The only thing that happens if you eat a great many is that you turn orange, which brings us to the next section.

Back to Table of Contents

Carotenemia: The Benign Orange Skin

Carotenemia — the high blood carotene level — and carotenoderma — the orange skin it produces — are the real, and entirely harmless, consequence of eating a great many carrots.

Because beta-carotene is fat-soluble, surplus that is not converted dissolves into subcutaneous fat and into the lipid-rich outer layer of the skin. Above a sustained intake in the region of 20 to 30 milligrams of carotene a day — roughly four to six large carrots daily, or a habitual glass of carrot juice, kept up for several weeks — the skin takes on a visible yellow-orange cast.

It shows first and most strongly where the skin's outer layer is thickest and sweat glands most numerous: the palms of the hands, the soles of the feet, the nasolabial folds beside the nose, and behind the ears. Maharshak and colleagues reviewed the literature in 2003 and describe exactly this distribution.

The single most useful clinical detail is this: in carotenoderma the whites of the eyes stay white. In jaundice they turn yellow, because bilirubin binds to elastin in the sclera and carotene does not. That one observation separates a person who has eaten a lot of carrots from a person with liver or bile duct disease, and it is the check a clinician makes first.

Carotenoderma is most often seen in infants and toddlers fed a lot of pureed carrot, sweet potato, and squash, and in adults on juice-heavy or very high vegetable diets. It causes no symptoms, damages nothing, and fades over weeks to a few months once intake falls. It needs no treatment; the colour fades as carrot intake falls.

One caveat worth stating: persistent yellow-orange skin is not always carotene. Hypothyroidism, diabetes, kidney disease, and liver disease can all raise blood carotene or produce similar discolouration, so colour that appears without a carrot-heavy diet can be a sign of one of these conditions rather than of carotene.

Back to Table of Contents

Macular Degeneration and the AREDS Story

There is one eye condition where carotenoids genuinely change outcomes, and it is instructive that the carotenoid involved is not beta-carotene.

The original Age-Related Eye Disease Study (AREDS) trial, reported in 2001, tested a formula of vitamin C, vitamin E, beta-carotene, zinc, and copper in people with age-related macular degeneration. In participants at high risk, the formula reduced progression to advanced disease by roughly a quarter over five years — a real and clinically meaningful result that put the AREDS formula into ophthalmology practice worldwide.

But the formula contained 15 milligrams of beta-carotene, and by then ATBC and CARET had reported. Prescribing it to a former smoker meant handing them the exact exposure two trials had linked to lung cancer. So AREDS2, published in JAMA in 2013, tested replacing beta-carotene with lutein and zeaxanthin — the two carotenoids that are actually concentrated in the macula, where they form the yellow macular pigment that filters blue light and quenches oxidative damage in the most metabolically stressed patch of the retina. The trial used lutein (10 mg) plus zeaxanthin (2 mg). Over a median follow-up of 5 years, adding them to the formula did not significantly reduce progression to advanced macular degeneration in the primary analysis (hazard ratio 0.90), and dropping beta-carotene had no apparent effect on progression; more lung cancers occurred with beta-carotene than without it (2.0% against 0.9%), mostly in former smokers, which is why the authors concluded that lutein and zeaxanthin could be an appropriate substitute. The substitution worked at least as well. The ten-year follow-up reported by Chew and colleagues in 2022 found, in a direct comparison, a potential benefit of lutein/zeaxanthin over beta-carotene for late macular degeneration (hazard ratio 0.85), while beta-carotene nearly doubled the odds of lung cancer (odds ratio 1.82).

The AREDS formula sold today therefore contains no beta-carotene at all. Two lessons follow. First, the carotenoids that protect the retina structurally are lutein and zeaxanthin, found in kale, spinach, egg yolk, and in smaller quantities in yellow carrots — not beta-carotene. Second, AREDS is a treatment for established macular degeneration, not a general eye supplement; it has never been shown to prevent the disease in people who do not have it.

Back to Table of Contents

How Much Vitamin A Carrots Supply, and What Helps Absorption

What the research shows about amounts, cooking and form.

One medium carrot supplies more than half of a day's vitamin A. A medium raw carrot supplies on the order of 500 micrograms RAE, against an adult requirement of 700 to 900. With other orange or dark green vegetables across the week, vitamin A ceases to be a concern. Carrots are not needed daily, and eating six brings no added benefit.

Cooking and fat raise absorption. These are the biggest levers. Gentle cooking softens the cell walls that trap beta-carotene, and dietary fat is required to get a fat-soluble pigment across the intestinal wall. Rock and colleagues reported in 1998, in eight women eating carrots and spinach for four weeks at a time, that the rise in blood beta-carotene from the processed vegetables averaged three times that from the same vegetables raw — a difference that fell short of statistical significance (P = 0.09), although only the processed period raised blood levels significantly above baseline; Brown and colleagues showed in 2004 that a fat-containing dressing markedly increased carotenoid absorption from salad compared with a fat-reduced one. Carrots roasted in olive oil, or raw carrots eaten with avocado, nuts, cheese, or a full-fat dip, deliver far more usable carotene than plain raw sticks. The companion page on cooking, fat, and absorption goes through the numbers.

Chopping or grating breaks cells open. Breaking cells mechanically does part of the job that heat does. In laboratory digestion tests in 2010, Lemmens and colleagues found that how much beta-carotene carrot particles released depended strongly on particle size for raw and gently cooked carrots, whereas after intense cooking a considerable amount was released even from larger cell clusters.

Long, hot cooking degrades beta-carotene. Prolonged high heat, especially in the presence of oil, degrades and isomerises beta-carotene. Steaming or brief roasting keeps the pigment; boiling for half an hour and discarding the water does not.

Other carrot colours add other pigments. Purple carrots add anthocyanins, red add lycopene, yellow add lutein. Arscott and Tanumihardjo's 2010 review makes the case that the heritage colour range is nutritionally broader than the orange monoculture.

Preformed vitamin A does not depend on conversion. Because conversion varies so much between people, a diet that includes eggs, whole dairy, oily fish, or occasional liver is a more robust vitamin A supply than plant carotenoids alone. This matters most for infants, for pregnancy, and for anyone eating no animal foods at all.

Beta-carotene supplements showed no benefit in the trials, and harm in smokers. In the trials above, beta-carotene supplements showed no benefit for cancer prevention, and in smokers, former smokers and asbestos-exposed workers they raised lung cancer.

Back to Table of Contents

Key Research Papers

  1. Wald G. Molecular basis of visual excitation. Science. 1968;162(3850):230-239. — doi:10.1126/science.162.3850.230
  2. Schoenlein RW, Peteanu LA, Mathies RA, Shank CV. The first step in vision: femtosecond isomerization of rhodopsin. Science. 1991;254(5030):412-415. — PubMed PMID: 1925597
  3. Lindqvist A, Andersson S. Biochemical properties of purified recombinant human beta-carotene 15,15'-monooxygenase. Journal of Biological Chemistry. 2002;277(26):23942-23948. — doi:10.1074/jbc.M202756200
  4. Grune T, Lietz G, et al. Beta-carotene is an important vitamin A source for humans. The Journal of Nutrition. 2010;140(12):2268S-2285S. — doi:10.3945/jn.109.119024
  5. Tang G. Bioconversion of dietary provitamin A carotenoids to vitamin A in humans. The American Journal of Clinical Nutrition. 2010;91(5):1468S-1473S. — doi:10.3945/ajcn.2010.28674G
  6. Haskell MJ. The challenge to reach nutritional adequacy for vitamin A: beta-carotene bioavailability and conversion — evidence in humans. The American Journal of Clinical Nutrition. 2012;96(5):1193S-1203S. — doi:10.3945/ajcn.112.034850
  7. Hickenbottom SJ, Follett JR, et al. Variability in conversion of beta-carotene to vitamin A in men as measured by using a double-tracer study design. The American Journal of Clinical Nutrition. 2002;75(5):900-907. — doi:10.1093/ajcn/75.5.900
  8. Leung WC, Hessel S, et al. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers. The FASEB Journal. 2009;23(4):1041-1053. — doi:10.1096/fj.08-121962
  9. Borel P, Desmarchelier C. Genetic variations associated with vitamin A status and vitamin A bioavailability. Nutrients. 2017;9(3):246. — doi:10.3390/nu9030246
  10. Novotny JA, Harrison DJ, et al. Beta-carotene conversion to vitamin A decreases as the dietary dose increases in humans. The Journal of Nutrition. 2010;140(5):915-918. — doi:10.3945/jn.109.116947
  11. Lietz G, Lange J, Rimbach G. Molecular and dietary regulation of beta,beta-carotene 15,15'-monooxygenase 1 (BCMO1). Archives of Biochemistry and Biophysics. 2010;502(1):8-16. — doi:10.1016/j.abb.2010.06.032
  12. Sommer A. Xerophthalmia and vitamin A status. Progress in Retinal and Eye Research. 1998;17(1):9-31. — doi:10.1016/S1350-9462(97)00001-3
  13. Sommer A. Vitamin A deficiency and clinical disease: an historical overview. The Journal of Nutrition. 2008;138(10):1835-1839. — doi:10.1093/jn/138.10.1835
  14. Imdad A, Mayo-Wilson E, Haykal MR, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database of Systematic Reviews. 2022;3(3):CD008524. — PubMed PMID: 35294044
  15. Wiseman EM, Bar-El Dadon S, Reifen R. The vicious cycle of vitamin A deficiency: a review. Critical Reviews in Food Science and Nutrition. 2017;57(17):3703-3714. — doi:10.1080/10408398.2016.1160362
  16. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine. 1994;330(15):1029-1035. — doi:10.1056/NEJM199404143301501
  17. Omenn GS, Goodman GE, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine. 1996;334(18):1150-1155. — doi:10.1056/NEJM199605023341802
  18. Hennekens CH, Buring JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New England Journal of Medicine. 1996;334(18):1145-1149. — doi:10.1056/NEJM199605023341801
  19. Druesne-Pecollo N, Latino-Martel P, et al. Beta-carotene supplementation and cancer risk: a systematic review and meta-analysis of randomized controlled trials. International Journal of Cancer. 2010;127(1):172-184. — doi:10.1002/ijc.25008
  20. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology. 2001;119(10):1417-1436. — doi:10.1001/archopht.119.10.1417
  21. Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA. 2013;309(19):2005-2015. — doi:10.1001/jama.2013.4997
  22. Chew EY, Clemons TE, et al. Long-term outcomes of adding lutein/zeaxanthin and omega-3 fatty acids to the AREDS supplements: AREDS2 report 28. JAMA Ophthalmology. 2022;140(7):692-698. — doi:10.1001/jamaophthalmol.2022.1640
  23. Maharshak N, Shapiro J, Trau H. Carotenoderma — a review of the current literature. International Journal of Dermatology. 2003;42(3):178-181. — doi:10.1046/j.1365-4362.2003.01657.x
  24. Arscott SA, Tanumihardjo SA. Carrots of many colors provide basic nutrition and bioavailable phytochemicals acting as a functional food. Comprehensive Reviews in Food Science and Food Safety. 2010;9(2):223-239. — doi:10.1111/j.1541-4337.2009.00103.x
  25. Rock CL, Lovalvo JL, Emenhiser C, et al. Bioavailability of beta-carotene is lower in raw than in processed carrots and spinach in women. The Journal of Nutrition. 1998;128(5):913-916. — PubMed PMID: 9567003
  26. Brown MJ, Ferruzzi MG, Nguyen ML, et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. The American Journal of Clinical Nutrition. 2004;80(2):396-403. — PubMed PMID: 15277161
  27. Lemmens L, Van Buggenhout S, Van Loey AM, Hendrickx ME. Particle size reduction leading to cell wall rupture is more important for the β-carotene bioaccessibility of raw compared to thermally processed carrots. Journal of Agricultural and Food Chemistry. 2010;58(24):12769-12776. — PubMed PMID: 21121612
  28. Live topic search — PubMed: beta-carotene vitamin A conversion in humans
  29. Live topic search — PubMed: carotenemia and carotenoderma

Back to Table of Contents

Connections

Back to Table of Contents